Recent Articles

Application of Protease Technology in Dermatology: Rationale for Incorporation into Skin Care with Initial Observations on Formulations Designed for Skin Cleansing, Maintenance of Hydration, and Restoration of the Epidermal Permeability Barrier

| June 13, 2013 | 0 Comments

James Q. Del Rosso, DO, FAOCD

Continue Reading

A Novel Glycinate-based Body Wash: Clinical Investigation Into Ultra-mildness, Effective Conditioning, and Improved Consumer Benefits

| June 13, 2013 | 0 Comments

Jamie Regan, MS; Leonel-Maximo Mollica; K.P. Ananthapadmanabhan, PhD

Continue Reading

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome

| June 13, 2013 | 0 Comments

Sonal Choudhary, MD; Michael McLeod, MS; Daniele Torchia, MD; Paolo Romanelli, MD Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida Disclosure: The authors report no relevant conflicts of interest. Abstract Drug rash with eosinophilia and systemic symptoms syndrome is a severe idiosyncratic drug reaction with a long latency [...]

Continue Reading

Penile Syringoma: Reports and Review of Patients with Syringoma Located on the Penis

| June 13, 2013 | 0 Comments

Philip R. Cohen, MD; Jaime A. Tschen, MD; Ronald P. Rapini, MD

Continue Reading

Neonate with Annular Plaques of the Scalp

| June 13, 2013 | 0 Comments

Jason Emer, MD; Adam Luber, BA; Mariyah Yazdani, MBBS; Brian Marciniak, BS; Harleen Sidhu, MD; Robert Phelps, MD

Continue Reading

NEW SECTION! Pediatric Dermatology

| May 23, 2013 | 0 Comments

Section Editor: Andrew Krakowski, MD Assistant Section Editors: Sheila Friedlander, MD; Andrea Zanglein, MD This month: Neonatal Lupus Erythematosus Presenting as Atypical Targetoid-like Lesions Involving Genitals and Soles of Feet Following Brief Sun Exposure by Shehla Admani, MD; Andrew C. Krakowski, MD

Continue Reading

Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib

| May 23, 2013 | 0 Comments

Philip R. Cohen, MD; Agop Y. Bedikian, MD; Kevin B. Kim, MD

Continue Reading